Detalhe da pesquisa
1.
KLHL22 activates amino-acid-dependent mTORC1 signalling to promote tumorigenesis and ageing.
Nature
; 557(7706): 585-589, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29769719
2.
Impact of multifocal or multicentric disease on local recurrence and survival in breast cancer patients with or without BRCA1/2 variants.
Breast Cancer Res Treat
; 199(1): 25-33, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36930346
3.
Prevalence of BRCA1 and BRCA2 pathogenic variants in 8627 unselected patients with breast cancer: stratification of age at diagnosis, family history and molecular subtype.
Breast Cancer Res Treat
; 195(3): 431-439, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35974241
4.
Neoadjuvant endocrine therapy for strongly hormone receptor-positive and HER2-negative early breast cancer: results of a prospective multi-center study.
Breast Cancer Res Treat
; 195(3): 301-310, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35917052
5.
Ovarian cancer risk of Chinese women with BRCA1/2 germline pathogenic variants.
J Hum Genet
; 67(11): 639-642, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35864222
6.
Predictors of sentinel lymph node metastasis in Chinese women with clinical T1-T2 N0 breast cancer and a normal axillary ultrasound.
Acta Radiol
; 63(11): 1463-1468, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34719964
7.
Impact of the addition of carboplatin to anthracycline-taxane-based neoadjuvant chemotherapy on survival in BRCA1/2-mutated triple-negative breast cancer.
Int J Cancer
; 148(4): 941-949, 2021 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32720318
8.
Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers in a large cohort of unselected Chinese breast cancer patients.
Int J Cancer
; 146(12): 3335-3342, 2020 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32037537
9.
BRCA1 c.5470_5477del, a founder mutation in Chinese Han breast cancer patients.
Int J Cancer
; 146(11): 3044-3052, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31957001
10.
Prevalence and clinical impact of TP53 germline mutations in Chinese women with breast cancer.
Int J Cancer
; 146(2): 487-495, 2020 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31119730
11.
Comparisons of breast conserving therapy versus mastectomy in young and old women with early-stage breast cancer: long-term results using propensity score adjustment method.
Breast Cancer Res Treat
; 183(3): 717-728, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32715444
12.
Effect of functional variant rs11466313 on breast cancer susceptibility and TGFB1 promoter activity.
Breast Cancer Res Treat
; 184(1): 237-248, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32757134
13.
Spectrum and clinical relevance of PALB2 germline mutations in 7657 Chinese BRCA1/2-negative breast cancer patients.
Breast Cancer Res Treat
; 179(3): 605-614, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31768816
14.
Germline mutation in DNA-repair genes is associated with poor survival in BRCA1/2-negative breast cancer patients.
Cancer Sci
; 110(10): 3368-3374, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31432574
15.
Risk of ipsilateral breast tumor recurrence in primary invasive breast cancer following breast-conserving surgery with BRCA1 and BRCA2 mutation in China.
Breast Cancer Res Treat
; 175(3): 749-754, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30895535
16.
Prevalence and characterization of ATM germline mutations in Chinese BRCA1/2-negative breast cancer patients.
Breast Cancer Res Treat
; 174(3): 639-647, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30607632
17.
Efficacy of pegfilgrastim to support neoadjuvant dose-dense epirubicin and cyclophosphamide chemotherapy in breast cancer.
Support Care Cancer
; 27(8): 3019-3025, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30607682
18.
RAD50 germline mutations are associated with poor survival in BRCA1/2-negative breast cancer patients.
Int J Cancer
; 143(8): 1935-1942, 2018 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29726012
19.
Predictive value of BRCA1/2 mRNA expression for response to neoadjuvant chemotherapy in BRCA-negative breast cancers.
Cancer Sci
; 109(1): 166-173, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29047188
20.
99mTc-rituximab as a tracer for sentinel lymph node biopsy in breast cancer patients: a single-center analysis.
Breast Cancer Res Treat
; 168(2): 365-370, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29209873